Why COVID vaccine development was exceptionally speedy
Ram May-Ron, Managing Partner at FreeMind Group, explains why COVID vaccine development was exceptionally speedy.
Countries denied access to vaccines they helped develop
A new study has revealed that new medicines and vaccines approved for use in the United States are often unavailable in countries that helped to develop them.
COVID-19 variant vaccines will be fast-tracked through cutting-edge testing centre
Health Secretary Matt Hancock has announced that vaccines tailored to tackle COVID-19 variants will be fast-tracked through new state-of-the-art labs.
Combination of remdesivir and hep C drugs effective against COVID-19
A combination of remdesivir and drugs for hepatitis C virus (HCV) have presented strong effectiveness against COVID-19 in a new study.
Ensuring regulatory compliance for Medical Cannabis
Here, Evolve Ltd’s Managing Director, Christopher Busuttil Delbridge, takes us progressively deeper into what it takes to ensure regulatory compliance for Medical Cannabis.
CBD oil for ADHD: What the research shows
CBD oil is popular for its wide-ranging therapeutic benefits, but what about its effects on ADHD? Here’s what the research shows.
Cannabis as a treatment for COVID-19
Kevin William Simpson, CEO and Founder of OilsBySimpson, tells us about the growing evidence around cannabis as a treatment for COVID-19.
CBD Novel Foods in the UK
Lead Scientific Officer at Always Pure Organics Andrew Megahy, explains how the UK is now in a prime position for the future of CBD use, due to the Novel Foods Application.
Benchmarking Regulatory systems governing veterinary medicines
Rick Clayton, Technical Director, AnimalhealthEurope, unpacks Benchmarking Regulatory systems governing veterinary medicines in this the first of a series of three articles.
Pharmaceuticals: Falsified medicines
Dr Ash Ramzan, Founder and Principal Consultant, Woodley BioReg Limited, turns the spotlight on falsified medicines in this pharmaceuticals focus.
Why are illegal pharma markets still prevalent today?
Professor Luis Diestre discusses the research and findings of his European Research Council funded Illegal Pharma Project, focussing on the ever popular market for counterfeit pharmaceuticals.
Cannabidiol, skin homeostasis and acne
Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains the potential of CBD and cannabinoids for skin care.
The UK’s legalisation of medicinal cannabis
David Hardstaff of BCL’s Cannabis Law & Regulatory team considers the success of the UK’s legalisation of medicinal cannabis products.
COVID-19 and drugs in the European neighbourhood partnership countries
The EU drugs agency explores the impact of COVID-19 on drug markets, use and services in the European neighbourhood partnership countries.
Medical cannabis in the UK and the industry’s future
Rick Brar, CEO & Chairman of Brains Bioceutical Corp. explores the landscape of medical cannabis in the UK and the future direction of the industry.
Drug prices in the U.S. are 2.56 times higher
Prescription drug prices in the United States are 2.56 times higher than in other countries, according to a new RAND Corporation report.
Antibiotics provide no benefit to COVID-19 patients
The PRINCIPLE trial has found that azithromycin and doxycycline do not provide any recovery benefits for COVID-19 patients.
Ivermectin effective in reducing mild COVID-19
A new study has found that early administration of ivermectin can reduce viral loads and symptom duration in patients with mild COVID-19.
EU finalises talks with Valneva to secure a new vaccine
Today, the European Commission concluded talks with Valneva to secure a new potential vaccine against COVID-19.
Kim Schleppegrell Skaue joins Oils By Simpson: Their mission to promote natural medicine
Read on to find out more about Oils By Simpson, Kim Schleppegrell Skaue, and their joint mission to encourage natural medicine use worldwide.
